GOSS R&D Expenses
Gossamer Bio Inc · R&D Expenses
GOSS R&D Expenses
Latest reported$171.44Mperiod ending
GOSS TTM R&D Expenses ($891.00K → $171.44M)
TTM R&D Expenses
High-resolution chart · PNG
GOSS r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 171,435,000 | |
| 186,598,000 | |
| 181,569,000 | |
| 168,746,000 | |
| 150,625,000 | |
| 144,136,000 | |
| 138,487,000 | |
| 132,345,000 | |
| 128,648,000 | |
| 129,871,000 | |
| 135,274,000 | |
| 146,812,000 | |
| 160,121,000 | |
| 166,392,000 | |
| 170,919,000 | |
| 170,343,000 | |
| 169,024,000 | |
| 170,762,000 | |
| 170,267,000 | |
| 168,245,000 | |
| 166,901,000 | |
| 161,267,000 | |
| 160,854,000 | |
| 164,540,000 | |
| 162,842,000 | |
| 159,834,000 | |
| 143,403,000 | |
| 126,679,000 | |
| 105,388,000 | |
| 77,642,000 | |
| 55,283,000 | |
| 30,086,000 | |
| 11,441,000 | |
| 3,513,000 | |
| 891,000 |